Karen T. Liby
- Molecular Biology top 0.5%
- Immunology top 2%
- Oncology top 2%
- Cancer Research top 2%
- Organic Chemistry top 5%
- Co-authors
- Michael B. SpornMark M. YoreCharlotte R. WilliamsGordon W. GribbleRenee RisingsongDarlene B. RoyceTadashi HondaThomas W. Kensler
- Topics
- Genomics, phytochemicals, and oxidative stress (53 papers)Natural product bioactivities and synthesis (15 papers)Retinoids in leukemia and cellular processes (13 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryNature reviews. Cancer
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Karen T. Liby
125 papers receiving 8.4k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Molecular Biology 6.5k
- Immunology 1.0k
- Oncology 988
- Cancer Research 873
- Organic Chemistry 682
Countries citing papers authored by Karen T. Liby
This map shows the geographic impact of Karen T. Liby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen T. Liby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen T. Liby more than expected).
Fields of papers citing papers by Karen T. Liby
This network shows the impact of papers produced by Karen T. Liby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen T. Liby. The network helps show where Karen T. Liby may publish in the future.
Co-authorship network of co-authors of Karen T. Liby
This figure shows the co-authorship network connecting the top 25 collaborators of Karen T. Liby. A scholar is included among the top collaborators of Karen T. Liby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen T. Liby. Karen T. Liby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 13 | |
| 3 | 1 | |
| 4 | 30 | |
| 5 | 13 | |
| 6 | 13 | |
| 7 | 31 | |
| 8 | 22 | |
| 9 | 2 | |
| 10 | 19 | |
| 11 | 1 | |
| 12 | 40 | |
| 13 | 78 | |
| 14 | 225 | |
| 15 | 143 | |
| 16 | 59 | |
| 17 | 282 | |
| 18 | 140 | |
| 19 | The triterpenoid, CDDO-methyl ester, and the rexinoid, LG100268, synergize in the prevention of mammary tumors in a mouse model of estrogen receptor-negative breast cancer. | 1 |
| 20 | The synthetic triterpenoid, CDDO-Imidazolide blocks nuclear factor-κB activation through direct inhibition of IκB kinase-beta. | 4 |
About Karen T. Liby
Karen T. Liby is a scholar working on Toxicology, Molecular Biology and Immunology, having authored 126 papers that have together received 8.6k indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (53 papers), Natural product bioactivities and synthesis (15 papers) and Retinoids in leukemia and cellular processes (13 papers). The work is most often cited by research in Toxicology (441 citations), Molecular Biology (6.5k citations) and Biological Psychiatry (166 citations). Karen T. Liby has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Michael B. Sporn, Mark M. Yore, Charlotte R. Williams, Gordon W. Gribble, Renee Risingsong, Darlene B. Royce, Tadashi Honda, Thomas W. Kensler, Melinda S. Yates and Masayuki Yamamoto. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature reviews. Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.